Jane Street
OLMA icon

Jane Street’s Olema Pharmaceuticals OLMA Stock Holding History

Jane Street’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-138,552
Closed -$521K – 10498
2025
Q1 		$521K Buy
138,552
+94,815
+217% +$477K ﹤0.01% 6786
2024
Q4 		$255K Sell
43,737
-3,969
-8% -$39.6K ﹤0.01% 8000
2024
Q3 		$570K Sell
47,706
-4,955
-9% -$63.3K ﹤0.01% 6965
2024
Q2 		$570K Buy
52,661
+17,007
+48% +$184K ﹤0.01% 6808
2024
Q1 		$404K Sell
35,654
-496
-1% -$6.4K ﹤0.01% 7071
2023
Q4 		$507K Buy
+36,150
New +$486K ﹤0.01% 6732
2023
Q3 		– Sell
-17,594
Closed -$159K – 9158
2023
Q2 		$159K Sell
17,594
-37,776
-68% -$228K ﹤0.01% 7783
2023
Q1 		$192K Buy
55,370
+43,964
+385% +$179K ﹤0.01% 7872
2022
Q4 		$27.9K Buy
+11,406
New +$33.3K ﹤0.01% 8522
2022
Q1 		– Sell
-15,040
Closed -$141K – 10825
2021
Q4 		$141K Buy
+15,040
New +$312K ﹤0.01% 9039

Other funds holding OLMA

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Jane Street's OLMA Position: Q2 2025 in Review

Jane Street sold out of Olema Pharmaceuticals (OLMA) in Q2 2025, closing a stake of 138,552 shares — an estimated $521K sold.

Jane Street first reported a position in OLMA in Q4 2021 and held it in 10 quarters. The position peaked at $570K in Q2 2024. 122 funds tracked by Wall St. Rank hold OLMA as of Q2 2025.

  • Jane Street reported no remaining Olema Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Jane Street sold 138,552 Olema Pharmaceuticals shares in Q2 2025, an estimated $521K.
  • Jane Street first reported a position in Olema Pharmaceuticals in Q4 2021 and held it in 10 quarters.
  • Jane Street's Olema Pharmaceuticals position peaked at $570K in Q2 2024.
  • 122 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2025.

Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.